CS logo
small CS logo
JEM Research Institute

Atlantis, Florida, United States
Doctor in Atlantis, Florida
130 John F Kennedy Dr STE 203, Lake Worth, FL 33462

About JEM Research Institute


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
9
Pfizer
8
Biogen
5
Neurotrope Bioscience, Inc.
3
TauRx Therapeutics Ltd
3
Athira Pharma
2
Eisai Inc.
2
Enterin Inc.
2
Otsuka Pharmaceutical Development & Commercialization, Inc.
2
Amgen
1
AstraZeneca
1
Total Rows: 31

Clinical Trials at JEM Research Institute


During the past decade, JEM Research Institute conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 26 clinical trials were completed, i.e. on average, 53.1% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 18 clinical trials were completed. i.e. 90% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years8866556644661010440033002233555566Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
2008-06-01
2013-08-01
Terminated
901
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
2008-01-01
2012-11-01
Terminated
1,100
A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy
2010-03-30
2011-07-06
Terminated
73
Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
2011-03-01
2014-11-01
Completed
806
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
2012-10-01
2016-05-01
Completed
800
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
2013-01-01
2015-11-01
Completed
891
Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia
2012-11-30
2013-11-30
Completed
754
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390

Rows per page:

1–58 of 58

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "JEM Research Institute" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Pfizer" with 8 trials sponsored, "Biogen" with 5 trials sponsored, "Neurotrope Bioscience, Inc." with 3 trials sponsored and "TauRx Therapeutics Ltd" with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 31 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "JEM Research Institute" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 3 trials as a collaborator, "Alzheimer's Association" with 2 trials as a collaborator, "Acorda Therapeutics" with 1 trials as a collaborator and "Alzheimer's Drug Discovery Foundation" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 9Eli Lilly and Company: 9Pfizer: 8Pfizer: 8Biogen: 5Biogen: 5Neurotrope Bioscience, Inc.: 3Neurotrope Bioscience, Inc.: 3TauRx Therapeutics Ltd: 3TauRx Therapeutics Ltd: 3Athira Pharma: 2Athira Pharma: 2Eisai Inc.: 2Eisai Inc.: 2Enterin Inc.: 2Enterin Inc.: 2Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:2Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:2Amgen: 1Amgen: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 4Eli Lilly and Company: 4National Institute onAging (NIA): 3National Institute onAging (NIA): 3Alzheimer's Association: 2Alzheimer's Association: 2Acorda Therapeutics: 1Acorda Therapeutics: 1Alzheimer's DrugDiscovery Foundation: 1Alzheimer's DrugDiscovery Foundation: 1Alzheimer's TherapeuticResearch Institute: 1Alzheimer's TherapeuticResearch Institute: 1Amgen: 1Amgen: 1Banner Alzheimer's Institute: 1Banner Alzheimer's Institute: 1Biogen: 1Biogen: 1Centessa Pharmaceuticals plc: 1Centessa Pharmaceuticals plc: 1

Clinical Trials Conditions at JEM Research Institute


According to Clinical.Site data, the most researched conditions in "JEM Research Institute" are "Alzheimer Disease" (19 trials), "Alzheimer's Disease" (12 trials), "Mild Cognitive Impairment" (4 trials), "Parkinson Disease" (3 trials) and "Constipation" (2 trials). Many other conditions were trialed in "JEM Research Institute" in a lesser frequency.

Clinical Trials Intervention Types at JEM Research Institute


Most popular intervention types in "JEM Research Institute" are "Drug" (52 trials), "Other" (7 trials), "Biological" (6 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (30 trials), "placebo" (5 trials), "Aducanumab" (4 trials), "Donanemab" (4 trials) and "ATH-1017" (2 trials). Other intervention names were less common.

Clinical Trials Genders at JEM Research Institute


The vast majority of trials in "JEM Research Institute" are 58 trials for "All" genders.

Clinical Trials Status at JEM Research Institute


Currently, there are NaN active trials in "JEM Research Institute". undefined are not yet recruiting, 13 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in JEM Research Institute, undefined suspended trials, and 12 terminated clinical trials to date.
Out of the total trials that were conducted in JEM Research Institute, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 31Phase 3: 31Phase 2: 25Phase 2: 25Phase 1: 2Phase 1: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 24Completed: 24Recruiting: 13Recruiting: 13Terminated: 12Terminated: 12Active, not recruiting: 8Active, not recruiting: 8Enrolling by invitation: 1Enrolling by invitation: 1